Integrated Diagnostics Holdings PLC (LSE:IDHC) Share Price

Company Profile

Business description
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
Contact
12 Castle Street
Saint HelierJE2 3RT
JEY
T: +44 1534847000
https://www.idhcorp.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
6,309

Recommended

We raise our risk and uncertainty rating to reflect the impact of the ruling.

Esther Holloway | 13 July 2025

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.

Sarah Hansen | 10 July 2025

Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.

Shaun Ler | 10 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,815.30	5.00	-0.06%
CAC 40	7,793.94	35.35	-0.45%
DAX 40	24,018.80	236.51	-0.98%
Dow JONES (US)	44,371.51	279.13	-0.63%
FTSE 100	8,975.78	34.66	0.39%
HKSE	24,203.32	63.75	0.26%
NASDAQ	20,585.53	45.14	-0.22%
Nikkei 225	39,459.62	110.06	-0.28%
NZX 50 Index	12,678.69	7.99	-0.06%
S&P 500	6,259.75	20.71	-0.33%
S&P/ASX 200	8,570.40	9.70	-0.11%
SSE Composite Index	3,519.65	9.47	0.27%